Daniel Lynch - 14 May 2025 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Reporting relationship: Director
Issuer ticker: SWTX
Reported as of: 14 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2025, 18:46:01 UTC
Prior SEC filing: 24 Feb 2025
Next SEC filing: 02 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact

Key filing fact

Daniel Lynch filed Form 4 for SpringWorks Therapeutics, Inc. (SWTX) on 15 May 2025.

Key facts

This page summarizes Daniel Lynch's Form 4 filing for SpringWorks Therapeutics, Inc. (SWTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2025, 18:46.

Change

Previous filing in this sequence was filed on 24 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001177082 Primary reporting owner

LYNCH DANIEL

Relationship: Director
Address: C/O SPRINGWORKS THERAPEUTICS, INC., 100 WASHINGTON BLVD., STAMFORD
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
Signature date: 15 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SWTX transaction

Common Stock

Award

Transaction value: $0
Shares: +10,060
Change %: +12%
Price: $0.000000
Shares after: 93,004
Date: 14 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The RSUs shall vest in full on the earlier of (i) May 14, 2026 and (ii) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.